A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.
<h4>Background</h4>Elderly people do not mount strong immune responses to vaccines. We compared 23-valent capsular polysaccharide (23vPPV) alone versus 7-valent conjugate (PCV7) vaccine followed by 23vPPV 6 months later in hospitalized elderly.<h4>Methods</h4>Participants wer...
Enregistré dans:
Auteurs principaux: | C Raina Macintyre, Iman Ridda, Zhanhai Gao, Aye M Moa, Peter B McIntyre, John S Sullivan, Thomas R Jones, Andrew Hayen, Richard I Lindley |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b99afa352a174a9f872b931ff9d6bcab |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
par: Yan Li, et autres
Publié: (2021) -
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
par: Pasiarski M, et autres
Publié: (2019) -
Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
par: Chee Fu Yung, et autres
Publié: (2021) -
Virulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccine.
par: Nelson Frazão, et autres
Publié: (2013) -
THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
par: I. V. Feldblum, et autres
Publié: (2014)